CareDx (CDNA) Tops Q2 EPS by 21c

CareDx (NASDAQ: CDNA) reported Q2 EPS of ($0.13), $0.21 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $80.6 million versus the consensus estimate of $81.85 million.

GUIDANCE:

CareDx sees FY2022 revenue of $325-335 million, versus the consensus of $338 million.

For earnings history and earnings-related data on CareDx (CDNA) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Robinhood prices $2B convertible notes offering due 2029
• MP Materials seen largely insulated after China export-control move